Beta Bionics, Inc. Common Stock (BBNX) Q3 2024 Earnings
BBNX·Reported January 31, 2025·After market close
Beta Bionics, Inc. Common Stock reported Q3 2024 revenue of $16.7M. Diluted EPS came in at $-1.55.
Revenue
$16.7M
Diluted EPS
$-1.55
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q3 2024 Earnings FAQ
Common questions about Beta Bionics, Inc. Common Stock's Q3 2024 earnings report.
Beta Bionics, Inc. Common Stock (BBNX) reported Q3 2024 earnings on January 31, 2025 after market close.
Beta Bionics, Inc. Common Stock reported revenue of $16.7M and diluted EPS of $-1.55 for Q3 2024.